2009Experimental PathologyRequires access

Expression of MMP-11(stromelysin-3) and its diagnostic value in dermatofibrosarcoma protuberans and dermatofibroma

Qixing Gong

Open publisher page 0 citations

Abstract

Purpose To investigate the expression pattern and the potential diagnostic value of MMP-11(stromelysin-3) in dermatofibrosarcoma protuberans and dermatofibroma.Methods Immunohistochemical markers,including MMP-11(stromelysin-3) and CD34,were used on the tissues of dermatofibrosarcoma protuberans and dermatofibroma by the SP immunohistochemical method.Western blotting was employed to detect MMP-11 expression.Results Immunohistochemically,positive staining of MMP-11(stromelysin-3)was seen in 28 of 30(93.3%) cases of dermatofibroma and 1 of 30(3.4%) cases of dermatofibrosarcoma protuberans,whereas by the expression pattern of MMP-11(stromelysin-3) between dermatofibrosarcoma protuberans and dermatofibroma had statistical difference(P0.05);positive staining of CD34 was seen in 27 of 30(90.0%) cases of dermatofibrosarcoma protuberans and in 2 of 30(6.7%) cases of dermatofibroma.The expression pattern of CD34 between dermatofibrosarcoma protuberans and dermatofibroma had statistical difference(P0.05).MMP-11 expression level in dermatofibroma was 6.18 times by that in dermatofibrosarcoma protuberans,which had significantly statistical difference(P0.01).Conclusions MMP-11(stromelysin-3) may be a useful immuneohistochemical marker in the differential diagnosis between dermatofibrosarcoma protuberans and dermatofibroma.

About this research paper

What this paper is about

Purpose To investigate the expression pattern and the potential diagnostic value of MMP-11(stromelysin-3) in dermatofibrosarcoma protuberans and dermatofibroma.Methods Immunohistochemical markers,including MMP-11(stromelysin-3) and CD34,were used on the tissues of dermatofibrosarcoma protuberans and dermatofibroma by the SP immunohistochemical method.Western blotting was employed to detect MMP-11 expression.Results Immunohistochemically,positive staining of MMP-11(stromelysin-3)was seen in 28 of 30(93.3%) cases of dermatofibroma and 1 of 30(3.4%) cases of dermatofibrosarcoma protuberans,whereas by the expression pattern of MMP-11(stromelysin-3) between dermatofibrosarcoma protuberans and dermatofibroma had statistical difference(P0.05);positive staining of CD34 was seen in 27 of 30(90.0%) cases of dermatofibrosarcoma protuberans and in 2 of 30(6.7%) cases of dermatofibroma.The expression pattern of CD34 between dermatofibrosarcoma protuberans and dermatofibroma had statistical difference(P0.05).MMP-11 expression level in dermatofibroma was 6.18 times by that in dermatofibrosarcoma protuberans,which had significantly statistical difference(P0.01).Conclusions MMP-11(stromelysin-3) may be a useful immuneohistochemical marker in the differential diagnosis between dermatofibrosarcoma protuberans and dermatofibroma.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Purpose To investigate the expression pattern and the potential diagnostic value of MMP-11(stromelysin-3) in dermatofibrosarcoma protuberans and dermatofibroma.Methods Immunohistochemical markers,including MMP-11(stromelysin-3) and CD34,were used on the tissues of dermatofibrosarcoma protuberans and dermatofibroma by the SP immunohistochemical method.Western blotting was employed to detect MMP-11 expression.Results Immunohistochemically,positive staining of MMP-11(stromelysin-3)was seen in 28 of 30(93.3%) cases of dermatofibroma and 1 of 30(3.4%) cases of dermatofibrosarcoma protuberans,whereas by the expression pattern of MMP-11(stromelysin-3) between dermatofibrosarcoma protuberans and dermatofibroma had statistical difference(P0.05);positive staining of CD34 was seen in 27 of 30(90.0%) cases of dermatofibrosarcoma protuberans and in 2 of 30(6.7%) cases of dermatofibroma.The expression pattern of CD34 between dermatofibrosarcoma protuberans and dermatofibroma had statistical difference(P0.05).MMP-11 expression level in dermatofibroma was 6.18 times by that in dermatofibrosarcoma protuberans,which had significantly statistical difference(P0.01).Conclusions MMP-11(stromelysin-3) may be a useful immuneohistochemical marker in the differential diagnosis between dermatofibrosarcoma protuberans and dermatofibroma.

Key concepts: Dermatofibrosarcoma protuberans, Dermatofibroma, Immunohistochemistry, CD34, Pathology, Dermatofibrosarcoma, Fibroma, Differential diagnosis

Related papers

Back to paper searchBrowse research topicsOriginal source
Expression of MMP-11(stromelysin-3) and its diagnostic value in dermatofibrosarcoma protuberans and dermatofibroma — Research Paper | ScholarLens